We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

77 hedge funds and large institutions have $384M invested in Coherus Oncology in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

19% more capital invested

Capital invested by funds: $322M → $384M (+$61.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

1% less funds holding

Funds holding: 78 → 77 (-1)

55% less call options, than puts

Call options by funds: $122K | Put options by funds: $272K

Holders
77
Holders Change
-1
Holders Change %
-1.28%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
30
Reduced
23
Closed
16
Calls
$122K
Puts
$272K
Net Calls
-$150K
Net Calls Change
+$1.32M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.4M
2
BFA
BlackRock Fund Advisors
California
+$12.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$7.24M
4
TA
Teachers Advisors
New York
+$2.38M
5
IHM
Iguana Healthcare Management
New York
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
TCP
Tourbillon Capital Partners
New York
-$15.7M
2
VM
VHCP Management
New York
-$6.67M
3
RFC
Russell Frank Company
Washington
-$4.54M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$3.25M
5
Fidelity International
Fidelity International
Bermuda
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$370 +$4.48K +174 +1%
TCP
77
Tourbillon Capital Partners
New York
– -$15.7M -784,176 Closed
Fidelity International
78
Fidelity International
Bermuda
– -$3.21M -160,152 Closed
CGI
79
CI Global Investments
California
– -$3.01M -150,000 Closed
Hudson Bay Capital Management
80
Hudson Bay Capital Management
Connecticut
– -$2.91M -145,261 Closed
Renaissance Technologies
81
Renaissance Technologies
New York
– -$1.71M -85,500 Closed
AA
82
ALPS Advisors
Colorado
– -$11.9K -59,228 Closed
TI
83
Trexquant Investment
Connecticut
– -$769K -38,400 Closed
EI
84
EAM Investors
California
– -$715K -35,656 Closed
PCM
85
Pyrrho Capital Management
New York
– -$544K -27,133 Closed
BCM
86
Bourgeon Capital Management
Connecticut
– -$351K -17,500 Closed
MLICM
87
Metropolitan Life Insurance Company (MetLife)
New York
– -$337K -16,813 Closed
Millennium Management
88
Millennium Management
New York
– -$224K -11,191 Closed
Goldman Sachs
89
Goldman Sachs
New York
– -$202K -10,083 Closed
SEI Investments
90
SEI Investments
Pennsylvania
– -$196K -9,773 Closed
First Manhattan
91
First Manhattan
New York
– -$100K -5,000 Closed
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
– -$26.3K -1,021 -99%
SSG
93
Summit Securities Group
New York
– -$2K -100 Closed
1 2 3
4

CHRS Hedge Fund Activity: Q4 2015 in Review

77 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q4 2015, worth a combined $384M — up 19% from $322M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of CHRS and 15 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 30 added.

The largest buyer was Fidelity Investments, adding an estimated $34.4M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $15.7M sold.

  • 77 institutional investors held Coherus Oncology (CHRS) as of Q4 2015, down from 78 in Q3 2015.
  • Funds reported $384M of Coherus Oncology stock for Q4 2015, up 19% quarter-over-quarter.
  • 15 funds opened new Coherus Oncology positions in Q4 2015 and 16 closed out, a net change of -1 holder.
  • The largest Coherus Oncology buyer in Q4 2015 was Fidelity Investments, an estimated $34.4M added.
  • The largest Coherus Oncology seller in Q4 2015 was Tourbillon Capital Partners, an estimated $15.7M sold.

Based on aggregated 13F filings for Q4 2015.